CORT Corcept Therapeutics Incorporated
Company Analysis
Latest News
🔴 Corcept Therapeutics is trading 4.7% down today on profit-taking after post-earnings surge
Corcept Therapeutics is trading at approximately $112.79, down 4.7% as the stock consolidates following a massive rally in the previous session. • Shares...
🟢 Corcept Therapeutics is trading 25% up today after a strong Q2 beat and raised revenue guidance
Corcept Therapeutics is trading 25% up at $115.95 after reporting a significant second-quarter earnings beat and sharply raising its long-term revenue...
🟢 Corcept Therapeutics is trading 26.5% up today on strong Q2 earnings beat and raised 2026 revenue guidance
Corcept Therapeutics is trading 26.5% up at $117.60 after a strong second-quarter earnings report that beat expectations and showcased a successful launch of...
Corcept's Cancer Drug Blowout Quarter Raises a Bigger Question: Can This One-Drug Company Become a Multi-Billion-Dollar Franchise?
Shares surged 20% to $111.55 in after-hours trading after Corcept Therapeutics crushed second-quarter expectations and raised full-year 2026 revenue guidance...
🟢 Corcept Therapeutics is trading 20% up today after beating Q2 estimates and raising full-year guidance
Corcept Therapeutics is trading at $111.55 (20% up) in after-hours trading after reporting second quarter 2026 results that significantly beat Wall Street...
Corcept Therapeutics' second quarter results crushed estimates, driven by a strong Lifyorli launch and raised guidance.
Corcept Therapeutics reported second quarter 2026 revenue of $256.1 million and diluted EPS of $0.36, significantly exceeding analyst expectations. The results...
Corcept Therapeutics Downgraded to Underperform, Wolfe Sets $50 Price Target
Wolfe Research downgraded Corcept Therapeutics (CORT) to Underperform from Peer Perform. Analysts established a $50.00 price target for the stock. This new...
Corcept Therapeutics Incorporated Q2 2026 Earnings Preview: What Analysts Expect on July 29, 2026
Corcept Therapeutics is expected to report a consensus revenue of $219.1 million and an EPS of $0.01, with the stock currently trading around $91.17 against a...
🔴 Corcept Therapeutics is trading 4.3% down today in an isolated pullback after recent gains
Corcept Therapeutics is trading 4.3% down at $91.34 in an isolated pullback following recent sharp gains, despite a lack of new fundamental headlines. • The...
🔴 Corcept Therapeutics is trading 4.3% down today after a volatile week
Corcept Therapeutics is trading 4.3% down at $91.23 in pre-market, pulling back after a volatile week that included several 4–6% swings. • The decline appears...
🟢 Corcept Therapeutics is trading 5.1% up
Corcept Therapeutics is trading at $95.50, up 5.1% from a comparison close of $90.88 during regular trading. This is a price-action follow-up, so a separate...
🟢 Corcept Therapeutics is trading 4.3% up today as Lifyorli approval and legal clarity drive investor demand
Corcept Therapeutics is trading 4.3% up at $95.53, rebounding as investors focus on the company's de-risked oncology franchise and clarity regarding historical...
🔴 Corcept Therapeutics is trading 4.4% down today amid intraday volatility
Corcept Therapeutics is trading at $86.45 (-4.44%) as of July 15, 2026, amid intraday volatility with no company-specific news to explain the move. • The...
🟢 Corcept Therapeutics Incorporated is trading 4.72% up in pre-market
CORT is trading at $94.74, up 4.72% in pre-market.
🟢 Corcept Therapeutics is trading 4.1% up today as shares rebound on relacorilant NDA resubmission optimism
Corcept Therapeutics is trading at $89.42 (up 4.1%) as shares rebound following yesterday’s profit-taking. • Investors remain optimistic after the company...
🔴 Corcept Therapeutics is trading 4.2% down today amid profit-taking after rally sparked by Cushing's syndrome drug NDA resubmission plan
Corcept Therapeutics is trading 4.2% down now at $88.06, experiencing profit-taking after a recent rally. • The stock surged following news on July 11, 2026,...
🟢 CORT is trading 4% up today, extending its recent uptrend on bullish sentiment
CORT is trading 4% up at $90.44, extending its strong recent uptrend despite a mixed broader market. • Recent analysis highlights bullish sentiment and upside...